McKesson Corporation (MCK)

US — Healthcare Sector
Peers: COR  CAH  HSIC  OMI  HUM  CI  LH 

Automate Your Wheel Strategy on MCK

With Tiblio's Option Bot, you can configure your own wheel strategy including MCK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MCK
  • Rev/Share 2867.8195
  • Book/Share -13.5304
  • PB -42.8294
  • Debt/Equity -3.5632
  • CurrentRatio 0.8993
  • ROIC 0.2659

 

  • MktCap 88618138960.0
  • FreeCF/Share 44.8163
  • PFCF 15.7936
  • PE 26.9585
  • Debt/Assets 0.0983
  • DivYield 0.004
  • ROE -1.3273

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 2
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Resumed MCK Mizuho -- Neutral -- $630 Dec. 4, 2024
Downgrade MCK Robert W. Baird Outperform Neutral $603 $531 Sept. 24, 2024
Reiterated MCK Leerink Partners -- Outperform $670 $665 Sept. 5, 2024

News

Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
BJ, DIS, MCK, RL
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive

DIS, BJ, RL, and MCK stand out with strong interest coverage ratios, making them attractive picks in a volatile market.

Read More
image for news Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
MCK
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Neutral

Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Read More
image for news Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
MCK
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More
image for news McKesson (MCK) Earnings Expected to Grow: Should You Buy?
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
MCK
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Read More
image for news 3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
Are Medical Stocks Lagging McKesson (MCK) This Year?
MCK
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Negative

Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.

Read More
image for news Are Medical Stocks Lagging McKesson (MCK) This Year?
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
MCK
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Neutral

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read More
image for news Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
MCK
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

Read More
image for news McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
CVS, MCK
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Read More
image for news Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Here's Why McKesson (MCK) is a Strong Value Stock
MCK
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why McKesson (MCK) is a Strong Value Stock
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
INCY, MCK
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Read More
image for news These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
MCK
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

Read More
image for news McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Why McKesson (MCK) is a Top Value Stock for the Long-Term
MCK
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why McKesson (MCK) is a Top Value Stock for the Long-Term
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
MCK
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Read More
image for news Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Here's Why McKesson (MCK) is a Strong Growth Stock
MCK
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Here's Why McKesson (MCK) is a Strong Growth Stock
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
MCK
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative

McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.

Read More
image for news McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
ACN, ADBE, EL, MCK
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive

These women-run company stocks offer high growth and stability.

Read More
image for news These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
MCK
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.

Read More
image for news Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
AEM, MCK, NTES, QFIN, UGI
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive

AEM, NTES, QFIN, UGI and MCK stand out as strong dividend growth picks for steady income and upside in 2H25.

Read More
image for news 5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
BURL, MCK, NOW, ROST, TJX
Published: June 25, 2025 by: CNBC Television
Sentiment: Neutral

The Investment Committee debate the latest Calls of the Day.

Read More
image for news Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
MCK
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More
image for news McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
4 Stocks With Solid Shareholder Yield to Safeguard Your Portfolio
CTSH, LRCX, MCK, RITM
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive

MCK, LRCX, CTSH, and RITM stand out with strong shareholder yield, blending income, buybacks and debt reduction for portfolio defense.

Read More
image for news 4 Stocks With Solid Shareholder Yield to Safeguard Your Portfolio
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
MCK
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive

Here is how McKesson (MCK) and Benitec Biopharma Limited (BNTC) have performed compared to their sector so far this year.

Read More
image for news Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
Here's Why McKesson (MCK) is a Strong Value Stock
MCK
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Here's Why McKesson (MCK) is a Strong Value Stock
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
MCK
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
MCK
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read More
image for news Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
MCK
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Read More
image for news McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
MCK
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Here is how McKesson (MCK) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Read More
image for news Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Why McKesson (MCK) is a Top Value Stock for the Long-Term
MCK
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Why McKesson (MCK) is a Top Value Stock for the Long-Term
Here's Why McKesson (MCK) is a Strong Momentum Stock
MCK
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Here's Why McKesson (MCK) is a Strong Momentum Stock
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
MCK
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More
image for news Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

About McKesson Corporation (MCK)

  • IPO Date 1994-11-10
  • Website https://www.mckesson.com
  • Industry Medical - Distribution
  • CEO Brian S. Tyler
  • Employees 44000

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.